Elite Pharmaceuticals, Inc. Cash and Restricted Cash
Elite Pharmaceuticals, Inc. (ELTP) had Cash and Restricted Cash of $39.42 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $39.42M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.27M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.56M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $39.42M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $30.27M 10-K · filed 2026-06-29 |
| 2025-12-31 | $21.56M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $27.08M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $22.20M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $11.77M 10-K · filed 2026-06-29 |
| 2024-12-31 | $8.74M 10-Q · filed 2026-02-17 |
| 2024-09-30 | $10.00M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $8.85M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $7.54M 10-K · filed 2025-06-30 |
| 2023-12-31 | $6.24M 10-Q · filed 2025-02-13 |
| 2023-09-30 | $9.08M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $9.49M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $8.24M 10-K · filed 2024-07-01 |
| 2022-12-31 | $18.31M 10-Q · filed 2024-02-14 |
| 2022-03-31 | $8.94M 10-K · filed 2023-06-29 |
| 2021-09-30 | $4.90M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.16M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.60M 10-K · filed 2022-06-29 |
| 2020-12-31 | $5.82M 10-Q · filed 2021-02-16 |
| 2020-09-30 | $4.77M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $3.19M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $1.54M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $2.27M 10-Q · filed 2021-02-16 |
| 2019-09-30 | $2.66M 10-Q · filed 2020-11-16 |
| 2019-06-30 | $2.98M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $2.68M 10-K · filed 2021-06-14 |
| 2018-12-31 | $4.08M 10-Q · filed 2020-02-10 |
| 2018-09-30 | $5.10M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $6.04M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $7.57M 10-K · filed 2020-06-29 |
| 2017-12-31 | $7.64M 10-Q · filed 2019-02-11 |
| 2017-09-30 | $7.95M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $9.96M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $10.98M 10-K · filed 2019-06-21 |